Skip to main content
CartClose Cart
Category

Announcement

Emma Maillard
In Announcement, new partnership

The EACR and CancerTools.org

The EACR and CancerTools.org sign a strategic partnership to accelerate cancer research and drive innovation

London, UK: CancerTools.org, the research tools arm of Cancer Research UK (CRUK), today announced a new partnership with the European Association for Cancer Research (EACR), with a shared mission to accelerate cancer research discoveries. The EACR is the first professional membership organisation to join the global cancer research tools collaborative led by CancerTools.org and CRUK.

The partnership with the EACR is designed to facilitate the success of this collaborative by reaching out to their membership of more than 10,000 cancer researchers to contribute research tools developed in their laboratories, so that other scientists globally can quickly benefit from them in their work. Progress in cancer research has always been dependent on the generosity and willingness of scientists to make their rare and unique materials available to their colleagues to confirm new results in the peer-review process and prevent ‘reinventing the wheel’ to recreate existing resources. CancerTools.org is the first non-profit programme to unite the entire global cancer research community in this important Mission.

As part of this partnership, CancerTools.org will develop a co-marketing collaboration plan with the EACR to benefit its membership to contribute and further develop the existing compendium of research tools. At the same time, the members will be able to access thousands of unique and innovative tools that already have been contributed by researchers from over 175 university partners on six continents at the www.cancertools.org website.

“By partnering with CancerTools.org, we will create new opportunities for our members by promoting the concept of contributing research tools to advance cancer research. This is an exciting opportunity to combine the forces of Cancer Research UK-led CancerTools.org and the EACR to expand the portfolio of research tools and make them quickly and easily accessible to cancer scientists worldwide”

Jane Smith, CEO of the EACR

“Partnering with the prestigious pan-European organization the EACR is a major milestone for CancerTools.org. Together we can work towards our shared mission of accelerating cancer research and drive innovation within this space. As a collaborative, we can reach out to the membership of the EACR and provide them with the only non-profit platform to effortlessly contribute their tools and make an impact in oncology research.”

Robert Bondaryk, Global Head, Research Tools, at CRUK

CancerTools.org offers cancer scientists a resource to contribute their research tools including antibodies, cell lines, organoids, experimental models, etc. and foster collaboration. Through this and various other partnerships, CancerTools.org aims to further reinforce its role as the leading non-profit global research tools collaborative in accelerating cancer research.

About CancerTools.org

CancerTools.org, the research tools arm of CRUK, is a non-profit, global community of cancer researchers, academic institutes and societies, with a shared mission to accelerate cancer research discoveries. In this collaborative, researchers contribute research tools and share knowledge to deepen our understanding of cancer, and drive innovation within cancer research.

About the EACR

The European Association for Cancer Research is a global community of cancer researchers with more than 10,000 members in 100+ countries. Membership is open to anyone working in or studying cancer research and members work across the full spectrum of the field, from basic through to translational and clinical research. The EACR offers collaboration, funding and networking opportunities and organises a full calendar of cancer research conferences.

About CRUK

Cancer Research UK (CRUK) is the world’s leading charity dedicated to beating cancer through research. It invests more than £400 million annually into cancer research through funding schemes, conferences, initiatives, resources, and a UK-wide network of research infrastructure across basic, translational, clinical and population research.
Emma Maillard
In Announcement

Nature article: CancerTools.org launch

https://ctnosalientud.wpengine.com/wp-content/uploads/Nature_Cancertools.org_article_2022.pdf
Emma Maillard
In Blog, Deposit your tools, new tools

How depositing your research tools can help to accelerate cancer research

Introduction

Research tools such as antibodies, cell lines, organoids, experimental models and other state of the art technologies form both a critical and valuable part of cancer research. These materials are fundamental- enabling scientists to conduct research, confirm results and prove their reproducibility- without them, the ways in which we understand cancer and the pioneering efforts had in prevention, diagnosis and treatment, would not be possible. The research tools you create can have long-term impact, even if they don’t have any clinical or drug development potential.

Your research tools are valuable to other likeminded cancer scientists, assisting the progression of new discoveries and supporting our shared mission of accelerating cancer research globally. Depositing your research tools can provide multiple advantages to both you and other scientists worldwide.

The home for your Cancer Research tools

Making your tools available to other scientists can be an arduous task and is yet another job to add into your already huge list of high priority tasks. CancerTools.org offers cancer scientists a single, centralised resource to contribute their cancer research tools towards. Depositing your research tool to CancerTools.org ensures that your tools are curated in one place for cancer investigators to seamlessly access thousands of unique materials from universities across all six continents on the cancertools.org website.

Support Cancer Research

Progress in cancer research has always been dependent on the generosity and willingness from scientists to make their unique materials available to their colleagues – in-fact, the peer review process to confirm new results is based on this very notion. Stemming from a spirit of depositing and collaboration, the CancerTools.org initiative leans closely to these values to help drive cancer research discoveries.

For scientists to be able to continually make progressions in the field, accessibility to the best research tools is crucial. Making your research tools available through the CancerTools.org portfolio grants this accessibility, enhances the influence of ongoing research, and allows other scientists to benefit from them across a range of cancer research areas. Your deposit ultimately supports the acceleration of discoveries and the ways in which we understand cancer globally.

”Good science needs the best research tools to carry it out. It is paramount that these research tools are widely and easily available to scientists so that we can maximise the opportunity for breakthroughs. At CancerTools.org, we are proud to be supporting cancer research by making these tools accessible to any scientist that needs them.

Robert Bondaryk, CancerTools.org Global Head.

Conclusion

CancerTools.org shares a mission with cancer researchers to accelerate cancer research. As Cancer Research UK’s research tools arm, tools accessed through CancerTools.org pay for future cancer research via a global revenue share to the inventing institute and to Cancer Research UK – the worlds largest cancer research charitable foundation.

To date, researchers from 175 academic institutes worldwide have deposited their research tools to the CancerTools.org biorepository. Why hold back? Join your colleagues globally in our shared mission to advance cancer research.

Deposit your research tools:

Find out more

Emma Maillard
In Blog, new tools

A collection of novel research tools

Introduction

We pride ourselves on our collaboration with many different institutes and organisations worldwide. In particular, the institutes who are pushing the boundaries of research tool production. It is these very collaborations that allows us to offer you such a vast range of novel and diverse research tools. Here are some examples of the unique research tools you can access through our portfolio.

PlasmaxTM

PlasmaxTM is a cell culture medium designed to imitate the physiological profile of human plasma. This medium allows you to: grow your cell cultures in conditions that realistically mirror human physiological conditions, simplify your medium preparation process, and reduce inter- and intra- experimental variability. Read our case study below to uncover more about the future of cancer cell culture.

Plasmax

Kinase Chemogenomic Set

Assembled by the SGC-UNC, the Kinase Chemogenomic Set (KCGS) is a collection of a narrow spectrum of small molecule kinase inhibitors, created to study the biology of dark kinases. Dark kinases are understudied kinases due to difficulty in detection, little biological information obtained around them, and their medical potential being untested. KCGS is unparalleled in the study of dark kinases within the human genome, and the discovery of new molecular targets for drug discovery.

KCGS

Recombinant Antibodies

Recombinant antibodies are rapidly expanding in popularity. Providing benefits in flexibility and reproducibility, they are increasingly being used in a variety of cancer research areas.

Discover our antibody collection

Cell lines

Simplifying your search for a wide variety of cell lines to add to your portfolios can help save you time. Our portfolio includes cell lines from a vast global network of institutes, including the laboratories of Nobel Prize winner, Sir Peter Ratcliffe; Charles Janeway, the father of Innate Immunity; industry leader, Professor Irene Leigh; and leading institutes such as the University of Cambridge, Uppsala University, and A*STAR in Singapore.

Explore our cell line collection

Explore our research tool portfolio

Access our tool collection

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.